Table 2.
Baseline characteristics of propensity score-matched population.
| Characteristic | No HF, N = 215 1 | HF, N = 215 1 | p-Value 2 |
|---|---|---|---|
| Age | 71 (62, 79) | 71 (62, 78) | >0.9 |
| Male | 171 (80%) | 174 (81%) | 0.7 |
| Hypertension | 147 (68%) | 148 (69%) | >0.9 |
| Diabetes mellitus type II | 57 (27%) | 53 (25%) | 0.7 |
| Dyslipidemia | 70 (33%) | 63 (29%) | 0.5 |
| Atrial fibrillation | 5 (2.3%) | 3 (1.4%) | 0.7 |
| Active smoker | 25 (12%) | 21 (9.8%) | 0.5 |
| COPD | 21 (9.8%) | 18 (8.4%) | 0.6 |
| Kidney disease | >0.9 | ||
| >85 mL/min | 44 (20%) | 46 (21%) | |
| 50–85 mL/min | 136 (63%) | 137 (64%) | |
| <50 mL/min | 35 (16%) | 32 (15%) | |
| Cardiogenic shock | 9 (4.2%) | 17 (7.9%) | 0.11 |
| Previous valve surgery | 0 (0%) | 0 (0%) | |
| Previous CABG | 0 (0%) | 0 (0%) | |
| Previous PCI | 7 (3.3%) | 6 (2.8%) | 0.8 |
| Previous AMI | 9 (4.2%) | 6 (2.8%) | 0.4 |
| LV function | 0.15 | ||
| Normal; EF >= 50% | 39 (18%) | 37 (17%) | |
| Moderately reduced, EF 41–49% | 107 (50%) | 90 (42%) | |
| Reduced, EF <= 40% | 69 (32%) | 88 (41%) | |
| ACS type | 0.4 | ||
| N-STEMI | 117 (54%) | 108 (50%) | |
| STEMI | 98 (46%) | 107 (50%) | |
| Time from MI to surgery | 0.5 | ||
| <6 h | 10 (4.7%) | 18 (8.4%) | |
| 6–24 h | 70 (33%) | 70 (33%) | |
| 1–7 days | 121 (56%) | 117 (54%) | |
| 8–21 days | 13 (6.0%) | 9 (4.2%) | |
| >21 days | 1 (0.5%) | 1 (0.5%) | |
| Number of diseased vessels | 0.9 | ||
| 1 | 33 (15%) | 30 (14%) | |
| 2 | 45 (21%) | 51 (24%) | |
| 3 | 115 (53%) | 115 (53%) | |
| >= 4 | 22 (10%) | 19 (8.8%) |
1 Median (IQR); n (%). 2 Wilcoxon rank sum test; Pearson’s chi-square test; Fisher’s exact test.